Skip to main content

Publisher: Oxford University Press

Volume 46, Number 3, 2014

A special issue on ‘Cancer’
pp. 169-169(1)
Authors: Xu, W.; Xu, M.

Favourites:
ADD

Tumor suppressor p53 and its gain-of-function mutants in cancer
pp. 170-179(10)
Authors: Liu, J.; Zhang, C.; Feng, Z.

Favourites:
ADD

The regulation of MDM2 oncogene and its impact on human cancers
pp. 180-189(10)
Authors: Zhao, Y.; Yu, H.; Hu, W.

Favourites:
ADD

Role of erbB3 receptors in cancer therapeutic resistance
pp. 190-198(9)
Authors: Lee, Y.; Ma, J.; Lyu, H.; Huang, J.; Kim, A.; Liu, B.

Favourites:
ADD

Regulation of protein stability of DNA methyltransferase 1 by post-translational modifications
pp. 199-203(5)
Authors: Scott, A.; Song, J.; Ewing, R.; Wang, Z.

Favourites:
ADD

Acetylation control of metabolic enzymes in cancer: an updated version
pp. 204-213(10)
Authors: Huang, W.; Wang, Z.; Lei, Q. Y.

Favourites:
ADD

Hypoxia and cancer cell metabolism
pp. 214-219(6)
Authors: Huang, D.; Li, C.; Zhang, H.

Favourites:
ADD
Favourites:
ADD

MicroRNAs and anticancer drugs
pp. 233-239(7)
Authors: Xing, Z.; Li, D.; Yang, L.; Xi, Y.; Su, X.

Favourites:
ADD

Mechanism of immunomodulatory drugs' action in the treatment of multiple myeloma
pp. 240-253(14)
Authors: Chang, X.; Zhu, Y.; Shi, C.; Stewart, A. K.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more